SAT-LB052 Intravenous Bisphosphonate Therapy in Children with Spinal Muscular Atrophy

Introduction: Children with Spinal Muscular Atrophy (SMA) are at high risk for poor bone health with 50% of the most severely affected patients reporting at least one fragility fracture prior to age 10 years. Intravenous bisphosphonate (IV BP) has been used for treatment of disuse osteoporosis, prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasomyont, Nat, Hornung, Lindsey, Wasserman, Halley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551666/
http://dx.doi.org/10.1210/js.2019-SAT-LB052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551666/
http://dx.doi.org/10.1210/js.2019-SAT-LB052

Ejemplares similares